Sanchez, L., Richter, J., Cho, H. J., Jagannath, S., Madduri, D., Parekh, S., . . . Chari, A. (2021). Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma. Ther Adv Hematol.
Styl ChicagoSanchez, Larysa, et al. "Subcutaneous Daratumumab and Hyaluronidase-fihj in Newly Diagnosed or Relapsed/refractory Multiple Myeloma." Ther Adv Hematol 2021.
Citace podle MLASanchez, Larysa, et al. "Subcutaneous Daratumumab and Hyaluronidase-fihj in Newly Diagnosed or Relapsed/refractory Multiple Myeloma." Ther Adv Hematol 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..